SCHEMBL5755339

SCHEMBL5755339

CC(C)(C)OC(=N)C(Cl)(Cl)Cl.CC(C)(C)OCc1nc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2)nc1C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 2/20 0.41
CDH1 P12830 1/20 0.34
APC P25054 1/20 0.34
CTNNB1 P35222 1/20 0.34
TCF7L2 Q9NQB0 1/20 0.34
KCNK3 O14649 4/20 0.34
KCNK9 Q9NPC2 4/20 0.34
PTGDR2 Q9Y5Y4 3/20 0.34
GAA P10253 1/20 0.33
SLC16A3 O15427 1/20 0.33
SLC16A1 P53985 1/20 0.33
MCTS1 Q9ULC4 1/20 0.33
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C8 P10632 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2A6 P11509 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
DHODH Q02127 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4680852 0.90 CNR1 (0.44) CNR1CDH1APCCTNNB1TCF7L2
SCHEMBL4683446 0.77 TARBP2 (0.50) CNR1GAADHODHNPC1RAB9A
SCHEMBL4681021 0.76 CNR1 (0.57) CNR1CDH1APCCTNNB1TCF7L2
SCHEMBL4677223 0.74 CNR1 (0.44) CNR1CDH1APCCTNNB1TCF7L2
SCHEMBL4676636 0.71 CNR1 (0.50) CNR1CDH1APCCTNNB1TCF7L2
SCHEMBL4681287 0.71 CNR1 (0.53) CNR1CYP2C9
SCHEMBL4681469 0.71 CDH1 (0.48) CNR1CDH1APCCTNNB1TCF7L2
SCHEMBL4676483 0.70 CNR1 (0.46) CNR1CDH1APCCTNNB1TCF7L2
SCHEMBL4677774 0.70 CNR1 (0.46) CNR1CDH1APCCTNNB1TCF7L2
SCHEMBL27634889 0.69 NR1H2 (0.39) CNR1CDH1APCCTNNB1TCF7L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1638953-A1 3-SUBSTITUTED 5,6-DIARYL-PYRAZINE-2-CARBOXAMIDE AND -2-SULFONAMIDE DERIVATIVES AS CB1 MODULATORS AstraZeneca AB (SE) 2006-03-29 EP disclosed
WO-2004111034-A1 3-SUBSTITUTED 5,6-DIARYL-PYRAZINE-2-CARBOXAMIDE AND -2-SULFONAMIDE DERIVATIVES AS CB1 MODULATORS ASTRAZENECA AB (SE) 2004-12-23 WO disclosed